BAP1 and uveal melanoma: Another limitation lies in the absence of BAP1 mutation data in our WCH cohort, which prevented us from conducting analyses or predictions specifically related to BAP1 mutational status, despite its well-established role as a key driver of aggressive tumor behavior and metastatic potential in uveal melanoma.